These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18946639)

  • 21. Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
    Harv Ment Health Lett; 2011 Apr; 27(10):1-3. PubMed ID: 21786468
    [No Abstract]   [Full Text] [Related]  

  • 22. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM
    Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Smoking cessation: varenicline/nicotine patch combination more effective than varenicline alone].
    Steurer J
    Praxis (Bern 1994); 2014 Oct; 103(21):1279-80. PubMed ID: 25305121
    [No Abstract]   [Full Text] [Related]  

  • 24. Smoking cessation and lung cancer: oncology nurses can make a difference.
    Cooley ME; Sipples RL; Murphy M; Sarna L
    Semin Oncol Nurs; 2008 Feb; 24(1):16-26. PubMed ID: 18222148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.
    Heitjan DF; Asch DA; Ray R; Rukstalis M; Patterson F; Lerman C
    Pharmacogenomics J; 2008 Dec; 8(6):391-9. PubMed ID: 18347612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varenicline: new drug. Smoking cessation: no better than nicotine.
    Prescrire Int; 2006 Dec; 15(86):210-2. PubMed ID: 17165237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
    Steinberg MB; Bover MT; Richardson DL; Schmelzer AC; Williams JM; Foulds J
    Drug Alcohol Depend; 2011 Mar; 114(1):77-81. PubMed ID: 20951511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the rate of usage of varenicline and other medication for smoking cessation.
    Kotz D; Fidler JA; West R
    Addiction; 2011 Oct; 106(10):1868-9; author reply 1869. PubMed ID: 21793957
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varenicline and bupropion sustained-release combination therapy for smoking cessation.
    Ebbert JO; Croghan IT; Sood A; Schroeder DR; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 Mar; 11(3):234-9. PubMed ID: 19246427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model.
    Knight C; Howard P; Baker CL; Marton JP
    Value Health; 2010; 13(2):209-14. PubMed ID: 19912599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy.
    Mariano ME; Elia D; Scarascia A; Tzani P; Giucastro G; Olivieri D; Marangio E
    Acta Biomed; 2009 Apr; 80(1):42-6. PubMed ID: 19705619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in health-related quality of life with smoking cessation treatment.
    Hays JT; Croghan IT; Baker CL; Cappelleri JC; Bushmakin AG
    Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking cessation in pregnancy: why, how, and what next..
    Crawford JT; Tolosa JE; Goldenberg RL
    Clin Obstet Gynecol; 2008 Jun; 51(2):419-35. PubMed ID: 18463471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking cessation intervention: an evidence-based approach.
    Laniado-Laborín R
    Postgrad Med; 2010 Mar; 122(2):74-82. PubMed ID: 20203458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D; Tappenden P; Peters J; Kenjegalieva K
    Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varenicline may reduce negative effect while aiding smoking cessation.
    Hays JT
    Evid Based Med; 2014 Feb; 19(1):23. PubMed ID: 23990527
    [No Abstract]   [Full Text] [Related]  

  • 40. [Specific program for smoking cessation: thus your patients become nonsmokers].
    Hering T
    MMW Fortschr Med; 2008 Nov; 150(46):42-3. PubMed ID: 19133359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.